Work

Outcomes of IDH1- and IDH2-Mutated AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Year: 2020

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2020-140353

Authors: Evan C. Chen, Shuli Li, Ann-Kathrin Eisfeld, Marlise R Luskin, Alice S. Mims, Daniel Jones, Joseph H. Antin, Corey Cutler, John Koreth, Vincent T. Ho, Mahasweta Gooptu, Rizwan Romee, Areej El-Jawahri, Steven L. McAfee, Zachariah Defilipp, Robert J. Soiffer, Yi-Bin Chen, Amir T. Fathi

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Harvard University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095350337

FWCI:

Cites:

Cited by:

Related to: 10